JACOBS LEVY EQUITY MANAGEMENT, INC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$85,000
-74.7%
327,173
-76.6%
0.00%
-71.4%
Q1 2016$336,000
+6620.0%
1,398,330
+9284.8%
0.01%
Q4 2015$5,000
-99.3%
14,900
-96.6%
0.00%
-100.0%
Q3 2015$766,000
+53.8%
440,377
+97.1%
0.02%
+77.8%
Q2 2015$498,000
+196.4%
223,474
+158.4%
0.01%
+200.0%
Q1 2015$168,000
-87.8%
86,470
-83.4%
0.00%
-87.5%
Q4 2014$1,381,000
+327.6%
521,078
+386.1%
0.02%
+380.0%
Q3 2014$323,000
-25.7%
107,200
+0.8%
0.01%
-28.6%
Q2 2014$435,000106,3000.01%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
CAXTON CORP 30,197,945$80,025,00092.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 457,458$1,212,0000.22%
Verity Asset Management, Inc. 82,383$218,0000.21%
STONERIDGE INVESTMENT PARTNERS LLC 332,238$880,0000.12%
Cutler Capital Management, LLC 62,500$165,0000.07%
Capital Impact Advisors, LLC 37,788$100,0000.05%
SECOR Capital Advisors, LP 35,087$93,0000.04%
STRATEGIC INVESTMENT MANAGEMENT, LLC 50,814$134,0000.04%
BOLTON LP 37,700$100,0000.03%
BOLTON LP 37,700$100,0000.03%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders